The FDA has approved a new formulation of oxymorphone extended-release tablets that is designed to be crush-resistant in order to reduce the potential for diversion and abuse.
According to the 2010 U.S. Bureau of Labor Statistics (BLS), approximately 3.1 million nonfatal workplace injuries and illnesses were reported in private industry in 2010, an incidence of 3.5 cases per 100 full-time workers. Skin diseases are the most common occupational illnesses, reported at 3.9 per 10,000 full-time workers, ahead of respiratory illnesses, hearing loss, and poisoning.
This study was a survey of all the physicians and nurses working in 82 adult ICUs on a particular day in 2010. It was conducted by a study group of the Ethics Section of the European Society of Intensive Care Medicine, and the ICUs involved were in nine European countries plus Israel.
Lemyze and colleagues studied a simple bedside procedure for detecting expiratory airflow obstruction in intubated, mechanically ventilated patients.
To examine the association between being placed in contact isolation and delirium, Day and colleagues at the University of Maryland Medical Center reviewed administrative data on all patients admitted during a 2-year period ending in 2009.
In this issue: New treatment for TB; safety of dabigatran; quality of antidepressants; systolic hypertension treatment; and FDA actions.
